EUVIMED · CrossrefZeitschrift
JAMA Psychiatry
ISSN 2168-622X · American Medical Association (AMA)
Neueste Artikel
The Validation Bottleneck for Psychiatric Biomarkers
Intolerance of Uncertainty Among US and Canadian Young Adults Attending College 1992-2023
Unreliability of Biomarker Research in Psychiatry
AI and the Irreplaceable in Clinical Psychiatry—In Defense of Essential Standards of Practice
Rethinking University Mental Health for the AI Era
Youth-Caregiver Discordance in Psychiatric Diagnosis and Clinical Problems in the ABCD Study
Office-Based Methadone Treatment—Has the Moment Arrived?
Further Clarification of Outcome Reporting in Clinical Trial
Further Clarification of Outcome Reporting in Clinical Trial—Reply
The Clinical Utility of AI-Based Prediction and Stratification Models
Claustrum Transcriptome Alterations in Schizophrenia
Mobile Units for Integrated Addiction and HIV Prevention Services for People Who Inject Drugs
Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry
Deaf and Hard-of-Hearing Competency in Psychiatric Practice
Reducing Ultraprocessed Foods From the Diets of Patients With Depression
Structural Brain Volumes and Delay Discounting
Placental Growth Factor Trajectories During Pregnancy and Child ADHD
Does Interacting With Artificial Intelligence Cause Delusions?
Neural Markers of Reward Valuation and Impulsive Decision-Making in Mania Risk
Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness
Potential for Genomics to Help Guide Preventive Strategies in Psychiatry
Angiotensin-Converting Enzyme in Patients With Early-Stage Psychosis
The Next Generation of Psychiatric Research—A Special Collection by Early Career Investigators
Rebalancing Global Suicide Prevention
Population-Level Implications of Parental Similarity for the Prevalence and Heritability of Psychiatric Disorders
Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time
Structural Brain Correlates of Bulimia Nervosa Diagnosis and Symptom Severity
The Case for More Aggressive Masking in Psychedelic Trials
Updating Treatment Goals for Schizophrenia
EUVIMED